ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer

Fu, Jinming; Du, Fenqi; Tian, Tian; Huang, Hao; Zhang, Lei; Li, Dapeng; Liu, Yupeng; Zhang, Ding; Gao, Lijing; Zheng, Ting; Liu, Yanlong; Zhao, Yashuang*哈尔滨医科大学
BMC CANCER2023-7-3DOI: 10.1186/s12885-023-11125-5
9閱讀
引用收藏
分享

摘要

BackgroundMetabolic derangements and systemic inflammation are related to the progression of colorectal cancer (CRC) and the prognoses of these patients. The survival of stage II and III CRC patients existed considerable heterogeneity highlighting the urgent need for new prediction models. This study aimed to develop and validate prognostic nomograms based on preoperative serum liver enzyme as well as evaluate the clinical utility.MethodsA total of 4014 stage II/III primary CRC patients pathologically diagnosed from January 2007 to December 2013 were included in this study. These patients were randomly divided into a training set (n = 2409) and a testing set (n = 1605). Univariate and multivariate Cox analyses were used to select the independent factors for predicting overall survival (OS) and disease-free survival (DFS) of stage II/III CRC patients. Next, nomograms were constructed and validated to predict the OS and DFS of individual CRC patients. The clinical utility of nomograms, tumor-node-metastasis (TNM), and the American Joint Committee on Cancer (AJCC) system was evaluated using time-dependent ROC and decision curve analyses.ResultsAmong seven preoperative serum liver enzyme markers, aspartate aminotransferase-to-alanine aminotransferase ratio (De Ritis ratio) was identified as an independent factor for predicting both OS and DFS of stage II/III CRC patients. The nomograms incorporated De Ritis ratio and significant clinicopathological features achieved good accuracy in terms of OS and DFS prediction, with C-index of 0.715 and 0.692, respectively. The calibration curve showed good agreement between prediction by nomogram and actual observation. The results of time-dependent ROC and decision curve analyses suggested that the nomograms had improved discrimination and greater clinical benefits compared with TNM and AJCC staging.ConclusionsDe Ritis ratio was an independent predictor in predicting both the OS and DFS of patients with stage II/III CRC. Nomograms based on De Ritis ratio and clinicopathological features showed better clinical utility, which is expected to help clinicians develop appropriate individual treatment strategies for patients with stage II /III CRC.

學科與關鍵詞

關鍵詞
Colorectal cancerPrognosisPreoperative serum liver enzyme markersDe Ritis ratioNomograms
相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
BMC CANCER
發表日期
2023-07-03
卷期
第 23 卷, 第 1 期
頁碼
620
DOI
10.1186/s12885-023-11125-5
語言
ENGLISH
成果收錄
SCIE

作者

  • F

    Fu, Jinming (第一作者)

    harbin med univ · xuzhou med univ

  • D

    Du, Fenqi

    harbin med univ

查看全部 12 位作者收起作者
  • T

    Tian, Tian

    harbin med univ

  • H

    Huang, Hao

    harbin med univ

  • Z

    Zhang, Lei

    harbin med univ

  • L

    Li, Dapeng

    harbin med univ

  • L

    Liu, Yupeng

    harbin med univ

  • Z

    Zhang, Ding

    harbin med univ

  • G

    Gao, Lijing

    harbin med univ

  • Z

    Zheng, Ting

    harbin med univ

  • L

    Liu, Yanlong

    harbin med univ

  • Z

    Zhao, Yashuang (通訊)

    harbin med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417